Skip to content
10-Q

Quarterly Report

INOZYME PHARMA, INC.

0000950170-24-091230

← back to feed
Filed
Aug 6, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 30, 2024 62.73M sh
Shares Diluted Q2 2024 · Jun 30, 2024 61.94M sh
Shares Diluted Q2 2024 · Jun 30, 2024 61.86M sh
Shares Diluted Q2 2024 · Jun 30, 2023 44.86M sh
Shares Diluted Q2 2024 · Jun 30, 2023 44.29M sh
Capex Q2 2024 · Jun 30, 2024 $32K
Capex Q2 2024 · Jun 30, 2023 $186K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$48.19M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$33.32M
Long Term Debt Q2 2024 · Jun 30, 2024 $45.33M
Long Term Debt Q2 2024 · Dec 31, 2023 $44.77M
Short Term Investments Q2 2024 · Jun 30, 2024 $129.29M
Short Term Investments Q2 2024 · Dec 31, 2023 $154M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $15.23M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $34.59M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $40.85M
Stockholders Equity Q2 2024 · Jun 30, 2024 $94.42M
Stockholders Equity Q2 2024 · Mar 31, 2024 $118.84M
Stockholders Equity Q2 2024 · Dec 31, 2023 $140.48M
Stockholders Equity Q2 2024 · Jun 30, 2023 $105.59M
Stockholders Equity Q2 2024 · Mar 31, 2023 $103.35M
Stockholders Equity Q2 2024 · Dec 31, 2022 $118.39M
Current Liabilities Q2 2024 · Jun 30, 2024 $15.54M
Current Liabilities Q2 2024 · Dec 31, 2023 $14.69M
Total Liabilities Q2 2024 · Jun 30, 2024 $61.29M
Total Liabilities Q2 2024 · Dec 31, 2023 $60.37M
Current Assets Q2 2024 · Jun 30, 2024 $152.96M
Current Assets Q2 2024 · Dec 31, 2023 $196.25M
Total Assets Q2 2024 · Jun 30, 2024 $155.71M
Total Assets Q2 2024 · Dec 31, 2023 $200.85M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.44
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.81
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.35
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.74
Eps Basic Q2 2024 · Jun 30, 2024 −$0.44
Eps Basic Q2 2024 · Jun 30, 2024 −$0.81
Eps Basic Q2 2024 · Jun 30, 2023 −$0.35
Eps Basic Q2 2024 · Jun 30, 2023 −$0.74
Sga Expense Q2 2024 · Jun 30, 2024 $5.91M
Sga Expense Q2 2024 · Jun 30, 2024 $11.14M
Sga Expense Q2 2024 · Jun 30, 2023 $4.73M
Sga Expense Q2 2024 · Jun 30, 2023 $11.24M
Rd Expense Q2 2024 · Jun 30, 2024 $21.76M
Rd Expense Q2 2024 · Jun 30, 2024 $40.87M
Rd Expense Q2 2024 · Jun 30, 2023 $11.67M
Rd Expense Q2 2024 · Jun 30, 2023 $23.52M
Net Income Q2 2024 · Jun 30, 2024 −$27.03M
Net Income Q2 2024 · Jun 30, 2024 −$50.38M
Net Income Q2 2024 · Mar 31, 2024 −$23.35M
Net Income Q2 2024 · Jun 30, 2023 −$15.58M
Net Income Q2 2024 · Jun 30, 2023 −$32.99M
Net Income Q2 2024 · Mar 31, 2023 −$17.4M
Operating Income Q2 2024 · Jun 30, 2024 −$27.67M
Operating Income Q2 2024 · Jun 30, 2024 −$52.01M
Operating Income Q2 2024 · Jun 30, 2023 −$16.39M
Operating Income Q2 2024 · Jun 30, 2023 −$34.76M